ProfileGDS5678 / 1429148_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 52% 49% 48% 53% 47% 46% 41% 49% 55% 49% 50% 48% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1673247
GSM967853U87-EV human glioblastoma xenograft - Control 23.2638652
GSM967854U87-EV human glioblastoma xenograft - Control 33.1733149
GSM967855U87-EV human glioblastoma xenograft - Control 43.0839648
GSM967856U87-EV human glioblastoma xenograft - Control 53.2644953
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.197847
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1587146
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9323541
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1554349
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3621555
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1549349
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1601550
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.132748
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2794253